Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
Nokia’s Acquisition of Infinera
Madhive’s Acquisition of Frequence
Wilson Sonsini Goodrich & Rosati advised Frequence on the transaction, and Latham & Watkins advised Madhive. Madhive, the leading technology company for local Connected Television advertising...
Amber Therapeutics’ $100 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Amber on the transaction. Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100...
Reunion Neuroscience’s $103 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
Entrust’s Acquisition of Onfido
Latham & Watkins represented Entrust in the transaction, and Wilson Sonsini Goodrich & Rosati represented Onfido. Entrust, a global leader in trusted payments, identities, and data...
ArteraAI’s $20 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised ArteraAI on the transaction. ArteraAI announced it has secured an additional $20 million in capital fueled by several prominent large...
ThayerMahan’s $20 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
Hyperexponential’s $73 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati represented Hyperexponential in the transaction. Osborne Clarke advised Highland Europe. Hyperexponential announced the closing of its $73 million Series B funding round led...
Renesas’ $339 Million Acquisition of Transphorm
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Boyu Capital’s Acquisition of Quasar Medical
Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
Coloplast’s $1.3 Billion Acquisition of Kerecis
Wilson Sonsini Goodrich & Rosati represented Kerecis on the transaction, while LOGOS Legal Services advised Kerecis on Icelandic law matters. Coloplast announced it has signed an agreement...